NDC Package 18124-016-01 Hydroxyprogesterone Caproate

Injection - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
18124-016-01
Package Description:
1 SYRINGE in 1 CARTON / 1.1 mL in 1 SYRINGE
Product Code:
Non-Proprietary Name:
Hydroxyprogesterone Caproate
Substance Name:
Hydroxyprogesterone Caproate
Usage Information:
This medication is used in women who are pregnant with a single baby, and who have delivered a baby too early (preterm) in the past. It is used to help lower the risk of having a preterm baby again. Hydroxyprogesterone is a man-made form of a female hormone (progestin). It is not known how it works to prevent preterm births. This medication is not intended to prevent preterm birth in women pregnant with more than one baby (such as twins, triplets). It is also not intended to stop active preterm labor.
11-Digit NDC Billing Format:
18124001601
Product Type:
Human Prescription Drug
Labeler Name:
Fresenius Kabi Austria Gmbh
Dosage Form:
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
02-03-2011
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 18124-016-01?

The NDC Packaged Code 18124-016-01 is assigned to an UNFINISHED drug package of 1 syringe in 1 carton / 1.1 ml in 1 syringe of Hydroxyprogesterone Caproate, a human prescription drug labeled by Fresenius Kabi Austria Gmbh. The product's dosage form is injection and is administered via form.

Is NDC 18124-016 included in the NDC Directory?

Yes, Hydroxyprogesterone Caproate is an UNFINISHED PRODUCT with code 18124-016 that is active and included in the NDC Directory. The product was first marketed by Fresenius Kabi Austria Gmbh on February 03, 2011 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 18124-016-01?

The 11-digit format is 18124001601. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-218124-016-015-4-218124-0016-01